Case Study: a major pharmaceutical company achieves $12.4M in savings with Exela Marketing Execution (XME)

a major pharmaceutical company saves $12.4M with Exela Technologies

The customer, a major pharmaceutical company, faced operational inefficiencies due to disparate systems across multiple states, which led to inconsistent asset fulfillment and high marketing material costs. A significant gap in understanding their marketing spend and asset management hindered their decision-making. To achieve a better ROI, they partnered with Exela Technologies for its Exela Marketing Execution (XME) solution.

Exela implemented a comprehensive solution that consolidated the client's marketing workflows into a single platform, providing a unified view of assets and campaigns. Through strategic sourcing and its AI-powered XME analytics tool, Exela streamlined operations, reduced material costs, and delivered pivotal insights for better targeting. This resulted in $12.4 million in savings, a 99.8% error-free quality assurance rate for print outsourcing, and the delivery of over 30,000 marketing materials and projects.